首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1574934

結核病檢測市場，按檢測類型、最終用戶、國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Tuberculosis Testing Market, By Test Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年10月02日 | 出版商:

AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023年結核病檢測市場規模為22.9032億美元，2024年至2032年複合年成長率為5.99%。

結核病檢測市場-市場動態

抗藥性結核菌株的日益普及推動了檢測需求。

抗藥性結核病（TB）菌株流行率的不斷上升是結核病檢測市場的重要推動力。隨著這些抗藥性菌株變得越來越常見，及時、準確的檢測對於有效治療至關重要。根據美國疾病管制與預防中心 (CDC) 的數據，美國新診斷的結核病病例中約有 3% 具有抗藥性。這項統計數據凸顯了對先進檢測解決方案的迫切需求，以有效識別和管理抗藥性菌株。醫療保健提供者需要可靠的診斷工具來確保適當的治療並控制結核病的傳播。隨著意識的增強，對創新測試方法的需求將持續成長，支持市場成長。

結核病檢測市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 5.99% 左右的複合年成長率成長

根據測試類型細分，預計分子診斷將在 2023 年顯示最大的市場佔有率

根據最終用戶細分，病理實驗室是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

結核病檢測市場-細分分析：

全球結核病檢測市場根據檢測類型、最終用戶和地區進行細分。

市場根據測試類型分為七類：射線照相方法、診斷實驗室方法、分子診斷、潛伏感染檢測、細胞激素檢測測定、抗藥性檢測（DST）、噬菌體測定和其他測試類型。在結核病檢測市場中，分子診斷，特別是聚合酶鏈反應（PCR）方法，是最主要的部分。 PCR 因其檢測結核分枝桿菌（即使是少量細菌）的速度和準確性而受到高度重視。這種方法可以快速診斷，這對於及時治療和控制疾病傳播至關重要。它識別抗藥性的能力也增強了治療選擇。因此，PCR 在推動結核病診斷和改善患者治療效果方面發揮關鍵作用。

市場根據最終用戶分為幾類：病理實驗室、即時檢測 (POCT) 和其他。在結核病檢測市場中，病理實驗室是最重要的環節。這些實驗室對於執行各種測試至關重要，包括培養方法和分子診斷。它們可以處理許多樣本並提供準確的結果，這對於診斷和管理結核病至關重要。他們的專業設備和訓練有素的員工確保正確完成複雜的測試。由於結核病仍然是一個主要的健康問題，病理實驗室的角色至關重要，使其成為市場的主導部分。

結核病檢測市場-地理洞察

北美結核病檢測市場專注於先進的診斷技術。美國和加拿大是該地區的領導者，在醫療保健和研究方面進行了大量投資。在美國，疾病管制與預防中心 (CDC) 促進結核病檢測和預防，提高人們對疾病的認知。對快速檢測方法（例如分子診斷）的需求日益成長，這有助於快速識別病例。政府計畫和資金也支持檢測，特別是針對高風險族群。市場上的主要公司推動創新並使測試變得更容易。總體而言，北美在改善結核病檢測和治療工作方面發揮著重要作用。

結核病檢測市場-競爭格局：

結核病檢測市場具有競爭格局，有幾個主要參與者。 Thermo Fisher Scientific 和 Roche 等公司在提供先進診斷工具方面處於領先地位。 Abbott Laboratories 和 BD 提供一系列有助於有效檢測結核病的檢查。 Cepheid 以其快速分子檢測解決方案而聞名，該解決方案正變得越來越受歡迎。

Hologic 和 QIAGEN 也貢獻創新技術來提高測試準確性。其他著名的參與者包括 BioMerieux 和 OxfordImmuntec，專注於專門的測試方法。這種產品的多樣性有助於滿足全球對高效結核病診斷不斷成長的需求。

概述
- 按測試類型分類的細分市場佔有率分析
- 射線照相法
- 診斷實驗室方法
  - 顯微鏡檢查
  - 基於文化的技術
  - 血清學檢測
- 分子診斷
  - 聚合酶鍊式反應 (PCR)
  - 核酸擴增檢驗（NAAT）
  - GeneXpert MTB/RIF
- 檢測潛伏感染
  - 結核菌素皮膚試驗（TST）
  - 干擾素-γ釋放測定（IGRA）
- 細胞激素檢測分析
- 抗藥性檢測（DST）
- 噬菌體測定
- 其他

第 8 章：結核病檢測市場 - 按最終用戶

概述
- 按最終用戶分類的細分市場佔有率分析
- 病理實驗室
- 即時檢測 (POCT)
- 其他

第 9 章：結核病檢測市場 - 按地理位置

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美結核病檢測主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按測試類型）
- 北美市場規模和預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲結核病檢測主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（按測試類型）
- 歐洲市場規模和預測（按最終用戶）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區結核病檢測主要製造商
- 亞太地區市場規模與預測（按國家）
- 按測試類型分類的亞太市場規模和預測
- 亞太地區市場規模和預測（按最終用戶）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲結核病檢測主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模和預測（按測試類型）
- 拉丁美洲市場規模和預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲結核病檢測主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按測試類型）
- 中東和非洲市場規模和預測（按最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 10 章：主要供應商分析 - 結核病檢測產業

競爭儀表板
公司簡介
- Thermo Fisher Scientific
- Roche
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Hologic
- Cepheid
- QIAGEN
- Molecular Testing Labs
- Siemens Healthineers
- Genomictree
- BioMerieux
- Oxford Immunotec
- F. Hoffmann-La Roche AG
- Eiken Chemical Co., Ltd.
- Hain Lifescience GmbH

第 11 章：360 度分析師視角

第 12 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV3933

REPORT HIGHLIGHT

Tuberculosis Testing Market size was valued at USD 2,290.32 million in 2023, expanding at a CAGR of 5.99% from 2024 to 2032.

The tuberculosis (TB) testing market refers to the industry that provides various tests to diagnose TB, a serious infectious disease that mainly affects the lungs. This market includes different types of tests, such as skin tests, blood tests, and imaging tests like X-rays. The demand for TB testing has increased due to the rising number of TB cases worldwide and the need for early detection and treatment. Many organizations, including governments and health agencies, invest in TB testing to control the disease. Overall, the TB testing market plays a crucial role in public health by helping to identify and treat those affected by the disease.

Tuberculosis Testing Market- Market Dynamics

The increasing prevalence of drug-resistant tuberculosis strains drives testing demand.

The increasing prevalence of drug-resistant tuberculosis (TB) strains is a significant driver for the tuberculosis testing market. As these resistant strains become more common, timely and accurate testing is essential for effective treatment. According to the Centers for Disease Control and Prevention (CDC), about 3% of newly diagnosed TB cases in the U.S. are drug-resistant. This statistic highlights the urgent need for advanced testing solutions to identify and manage resistant strains effectively. Healthcare providers require reliable diagnostic tools to ensure appropriate treatment and control the spread of TB. As awareness grows, the demand for innovative testing methods will continue to rise, supporting market growth.

Tuberculosis Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.99% over the forecast period (2024-2032)

Based on Test Type segmentation, Molecular diagnostics was predicted to show maximum market share in the year 2023

Based on End-user segmentation, Pathological laboratories was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Tuberculosis Testing Market- Segmentation Analysis:

The Global Tuberculosis Testing Market is segmented based on Test Type, End User, and Region.

The market is divided into Seven categories based on Test Type: Radiographic method, Diagnostic laboratory methods, Molecular diagnostics, Detection of latent infection, Cytokine detection assay, Detection of drug resistance (DST), Phage assay, and other test types. In the tuberculosis testing market, Molecular diagnostics, particularly the Polymerase Chain Reaction (PCR) method, is the most dominant segment. PCR is highly valued for its speed and accuracy in detecting Mycobacterium tuberculosis, even in small amounts of bacteria. This method allows for quick diagnosis, which is crucial for initiating timely treatment and controlling the spread of the disease. Its ability to identify drug resistance also enhances treatment options. As a result, PCR plays a key role in advancing tuberculosis diagnostics and improving patient outcomes.

The market is divided into categories based on End Users: Pathological laboratories, Point of care testing (POCT), and Others. In the tuberculosis testing market, pathological laboratories are the most important segment. These labs are essential for performing various tests, including culture methods and molecular diagnostics. They can handle many samples and provide accurate results, which is vital for diagnosing and managing TB. Their specialized equipment and trained staff ensure that complex tests are done correctly. As TB continues to be a major health issue, the role of pathological laboratories is crucial, making them the leading segment in the market.

Tuberculosis Testing Market- Geographical Insights

The North American tuberculosis testing market focuses on advanced diagnostic technologies. The United States and Canada are the leaders in this region, with significant investments in healthcare and research. In the U.S., the Centers for Disease Control and Prevention (CDC) promotes TB testing and prevention, raising awareness about the disease. There is a growing need for rapid testing methods, like molecular diagnostics, which help identify cases quickly. Government programs and funding also support testing, especially for high-risk groups. Major companies in the market drive innovation and make testing more accessible. Overall, North America plays an important role in improving tuberculosis testing and treatment efforts.

Tuberculosis Testing Market- Competitive Landscape:

The tuberculosis testing market features a competitive landscape with several key players. Companies like Thermo Fisher Scientific and Roche lead in providing advanced diagnostic tools. Abbott Laboratories and BD offer a range of tests that help detect TB effectively. Cepheid is known for its rapid molecular testing solutions, which are becoming increasingly popular.

Hologic and QIAGEN also contribute innovative technologies to improve testing accuracy. Other notable players include BioMerieux and Oxford Immunotec, focusing on specialized testing methods. This diversity in offerings helps meet the growing demand for efficient tuberculosis diagnostics worldwide.

Recent Developments:

In November 2023, BD and Bio Farma signed a memorandum of understanding (MOU) to work together on addressing tuberculosis. BD offered access to its advanced TB diagnostic tools, while the partnership improved the supply chain for TB solutions in Indonesia.

In February 2023, Fisher Scientific launched real-time PCR kits in India for detecting various infectious diseases. These kits cover a range of conditions, including genetic analysis (HLA B27), Multi-Drug-Resistant Tuberculosis (MTB MDR), Hepatitis B Virus (HBV), M. Tuberculosis complex (MTB), Human Immunodeficiency Virus (HIV), and Hepatitis C Virus (HCV).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TUBERCULOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific
Roche
Abbott Laboratories
BD (Becton, Dickinson, and Company)
Hologic
Cepheid
QIAGEN
Molecular Testing Labs
Siemens Healthineers
Genomictree
BioMerieux
Oxford Immunotec
F. Hoffmann-La Roche AG
Eiken Chemical Co., Ltd.
Hain Lifescience GmbH

GLOBAL TUBERCULOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

Radiographic method
Diagnostic laboratory methods
Microscopy
Culture-based techniques
Serological tests
Molecular diagnostics
Polymerase chain reaction (PCR)
Nucleic acid amplification tests (NAAT)
GeneXpert MTB/RIF
Detection of latent infection
Tuberculin skin test (TST)
Interferon-gamma release assays (IGRAs)
Cytokine detection assay
Detection of drug resistance (DST)
Phage assay
Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Pathological laboratories
Point of care testing (POCT)
Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Tuberculosis Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Tuberculosis Testing Market Snippet by Test Type
- 2.1.2. Tuberculosis Testing Market Snippet by End User
- 2.1.3. Tuberculosis Testing Market Snippet by Country
- 2.1.4. Tuberculosis Testing Market Snippet by Region
2.2. Competitive Insights

3. Tuberculosis Testing Key Market Trends

3.1. Tuberculosis Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Tuberculosis Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Tuberculosis Testing Market Opportunities
3.4. Tuberculosis Testing Market Future Trends

4. Tuberculosis Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Tuberculosis Testing Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Tuberculosis Testing Market Landscape

6.1. Tuberculosis Testing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Tuberculosis Testing Market - By Test Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
- 7.1.2. Radiographic method
- 7.1.3. Diagnostic laboratory methods
  - 7.1.3.1. Microscopy
  - 7.1.3.2. Culture-based techniques
  - 7.1.3.3. Serological tests
- 7.1.4. Molecular diagnostics
  - 7.1.4.1. Polymerase chain reaction (PCR)
  - 7.1.4.2. Nucleic acid amplification tests (NAAT)
  - 7.1.4.3. GeneXpert MTB/RIF
- 7.1.5. Detection of latent infection
  - 7.1.5.1. Tuberculin skin test (TST)
  - 7.1.5.2. Interferon-gamma release assays (IGRAs)
- 7.1.6. Cytokine detection assay
- 7.1.7. Detection of drug resistance (DST)
- 7.1.8. Phage assay
- 7.1.9. Others

8. Tuberculosis Testing Market - By End User

8.1. Overview
- 8.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 8.1.2. Pathological laboratories
- 8.1.3. Point of care testing (POCT)
- 8.1.4. Others

9. Tuberculosis Testing Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Tuberculosis Testing Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Tuberculosis Testing Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.8. United Kingdom
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.9. France
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.10. Russia
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.10.3. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.11. Netherlands
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.13. Poland
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.3.14. Rest of Europe
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.3.14.4. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Tuberculosis Testing Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Tuberculosis Testing Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Tuberculosis Testing Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Tuberculosis Testing Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Thermo Fisher Scientific
- 10.2.2. Roche
- 10.2.3. Abbott Laboratories
- 10.2.4. BD (Becton, Dickinson and Company)
- 10.2.5. Hologic
- 10.2.6. Cepheid
- 10.2.7. QIAGEN
- 10.2.8. Molecular Testing Labs
- 10.2.9. Siemens Healthineers
- 10.2.10. Genomictree
- 10.2.11. BioMerieux
- 10.2.12. Oxford Immunotec
- 10.2.13. F. Hoffmann-La Roche AG
- 10.2.14. Eiken Chemical Co., Ltd.
- 10.2.15. Hain Lifescience GmbH